Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of General Meeting

28th Apr 2026 10:51

RNS Number : 2327C
Fortis Frontier PLC
28 April 2026
 

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Result of General Meeting

 

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that at general meeting held earlier today both resolutions were passed.

 

As such the EIS Buyback Agreement and the GP Buyback Agreement, to purchase, in aggregate, 13,717,619 Ordinary Shares from Mercia, as notified in the Company's announcement of 1 April 2026, are expected to complete shortly. The Buyback Shares will be cancelled.

 

Resolution

For

% For

Against

% Against

Withheld

1. To approve the terms of the EIS Buyback Agreement

8,581,297

98.47%

132,980

1.53%

9,728

2. To approve the terms of the GP Buyback Agreement

8,581,297

98.47%

132,980

1.53%

9,728

 

 

Total Voting Rights

Following cancellation, the Company's issued ordinary share capital will consist of 36,148,766 Ordinary Shares, with one vote per share. As the Company does not hold any Ordinary Shares in treasury this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Unless otherwise defined, all definitions used in this announcement will have the same meaning as described in the Circular dated 1 April 2026.

For further information contact:

 

Fortis Frontier PLC

www.fortisfrontierplc-ir.com

Adam Reynolds, Executive Chairman

via Walbrook PR

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin / Dillon Wall

Singer Capital Markets (Broker)

Tel: +44 (0)20 7496 3000

James Serjeant / Russell Cook / Amber Higgs

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFIFSASTITFIR

Related Shares:

Fortis Frontier
FTSE 100 Latest
Value10,191.66
Change-141.13